KaloBios
Humaneering™ Technology

Analysis of Human Antibodies

The Colony Lift Binding Assay (shown below) demonstrates how panels of clones, all with the identical specificity, are produced; however, the composition and physical characteristics of each clone is distinct, affording ample opportunity to screen for clones containing all the desired properties of the target therapeutic.



Clones are selected for Ka, Kd, closeness-to-human germline, stability, expression, aggregation, etc. Below are shown the aggregation profiles (SEC-HPLC) for five Humaneered™ clones. Two clones show undetectable aggregation and will be included for further analysis on the screening cascade.




<-- Return to Strategy for Producing Humaneered™ Antibodies

copyright ©2010 KaloBios Pharmaceuticals, Inc

 

 

 

 

copyright ©2010 KaloBios Pharmaceuticals, Inc.